Sigesa renews the “Innovative SME” seal of approval

Sigesa has recently renewed the “Innovative SME” seal that the Ministry of Science, Innovation and Universities, through its Directorate General for Research, Development and Innovation, awards to Spanish companies with proven experience in innovation and research.

This seal is a direct recognition of the efforts and investments in innovation, research and development that the company has made in recent years.

Innovation is a strategic asset for Sigesa. As a result, the company’s R+D+I department has become a key function in recent years, and is the pillar on which the company’s growth strategy is based.

Among the latest research projects in which Sigesa has participated are:

  • PREDIHEALTH: System for improving the management and efficiency of healthcare centres through new predictive models. 
  • COVID-X: COVID-19 (COVID-MRP) Patient Severity and Risk of Mortality Prediction System
  • Urg-SAA: System for standardisation, validation and advanced analysis of emergency department activity
  • SISAHRQ: New advanced hospital quality information system
  • SISPharma: System for analysing the impact of prescribing patterns on the care processl